Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric genitourinary tumors.

Sharon M Castellino1, Thomas W McLean

  • 1Department of Pediatrics, Hematology/Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. scastell@wfubmc.edu

Current Opinion in Oncology
|April 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoglobulin Supplementation Practices and Effects During Pediatric B-Cell Acute Lymphoblastic Leukemia Therapy.

Journal of pediatric hematology/oncology·2026
Same author

Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Subsequent Neoplasm Risk After Modern Mediastinal Radiation Therapy for Pediatric Hodgkin Lymphoma: Insights From a Multi-Institutional Children's Oncology Group Trial.

International journal of radiation oncology, biology, physics·2026
Same author

Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment.

Journal of adolescent and young adult oncology·2026
Same author

Imaging pitfalls in pediatric, adolescent, and young adult hodgkin lymphoma: a SEARCH for CAYAHL initiative to bridge multidisciplinary patient care.

Journal of the National Cancer Institute·2026
Same author

Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL Group.

British journal of haematology·2026
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Survival rates for childhood genitourinary cancers are improving. Advances in chemotherapy, molecular markers, and risk-stratified therapy enhance individualized treatment for pediatric renal, bladder, prostate, and testicular tumors.

Area of Science:

  • Pediatric Oncology
  • Genitourinary Oncology
  • Molecular Oncology

Background:

  • Pediatric genitourinary tumors encompass a range of malignancies affecting children.
  • Significant advancements have been made in understanding and treating these rare cancers.
  • The 2005-2006 literature provides a snapshot of contemporary approaches.

Purpose of the Study:

  • To review the 2005 and 2006 scientific literature concerning pediatric genitourinary tumors.
  • To synthesize key findings and trends in the management of these cancers.

Main Methods:

  • Literature review of publications from 2005-2006.
  • Analysis of studies focusing on renal, bladder, prostate, and testicular tumors in children.
  • Synthesis of data on treatment outcomes, prognostic factors, and emerging technologies.

Related Experiment Videos

Main Results:

  • Survival rates for primary renal, bladder/prostate, and testicular tumors show continued improvement.
  • Intensified chemotherapy for anaplastic histology and molecular markers for renal tumors aid individualized therapy.
  • Loss of heterozygosity for chromosomes 1p and 16q identified as adverse prognostic factor in Wilms' tumor.
  • Anaplastic histology and bilateral Wilms' tumor present ongoing challenges.
  • Genitourinary site and embryonal histology indicate a favorable prognosis in rhabdomyosarcoma.

Conclusions:

  • Molecular oncology, advanced imaging, surgical techniques, and long-term survivor follow-up are crucial.
  • These advances drive risk-stratified therapeutic strategies for pediatric genitourinary tumors.
  • Personalized medicine approaches are increasingly important in optimizing outcomes.